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Abstract 
Background:  Nearly one in three women in the 
United States are affected by bacterial vaginosis 
at some point in their life, with more than fifty 
percent experiencing recurrent symptoms within 
12 months.   
Case:  A 36 year old G9P2072 with 1 year 
history of recurrent bacterial vaginosis despite 
repeated treatments with local and systemic 
metronidazole, metronidazole suppression, and 
probiotic therapy had relief of bacterial vaginosis 
following triple antibiotic therapy for Helicobacter 
pylori.  She remains asymptomatic for both 
bacterial vaginosis and Helicobacter pylori at 6 
month follow up. 
Discussion:  We present a woman with recurrent 
bacterial vaginosis who had sudden relief of her 
symptoms following treatment for Helicobacter 
pylori.  While association should not be 
construed as causation, similar pathogenesis 
may warrant investigation of H pylori as a 
potential cause of the complex change in the 
vaginal flora leading to bacterial vaginosis.   
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Background 
Bacterial vaginosis is the most common 
cause of vaginal discharge in women of 
childbearing age, affecting nearly one in 
three women in the United States.1  
Bacterial vaginosis causes a wide range 
of consequences for these women, 
including a significant emotional burden 
and an increased risk for both adverse 
pregnancy outcomes and sexually 
transmitted infections.  Qualitative 
studies have linked bacterial vaginosis 
with women feeling dirty, embarrassed, 
ashamed, self-conscious, and frustrated 
over a lack of control over their 
symptoms, leading to negative 
consequences for themselves and their 
sexual relationships.2,3 These feelings 
often lead women to perform self-
hygienic practices, including douching 
and use of fragrant soaps, lotions, and 
powders to try and gain some element 
of control over their condition.4 
Unfortunately, many of these practices 
may contribute to bacterial vaginosis or 
recurrence of symptoms.  The medical 
consequences of bacterial vaginosis 
include higher rates of preterm birth in 
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pregnant patients and increased risk of 
contracting sexually transmitted 
infections.5   
Case  
A 36 year old G9P2072 was referred to 
our tertiary care vulvar vaginal disease 
clinic for a 1 year history of recurrent 
bacterial vaginosis treated multiple 
times with local and systemic 
metronidazole.  She noted resolution of 
symptoms with each treatment.  Besides 
a new male sex partner and inconsistent 
condom use, she denied known risk 
factors for recurrent bacterial vaginosis 
including multiple sexual partners, sex 
with women, douching, and use of sex 
toys.  Her past medical history was 
significant for gastro-esophageal reflux 
disease, poorly controlled with 
omeprazole, carpal tunnel syndrome 
requiring surgery during this time period, 
and a benign thyroid cyst.  Medications 
included omeprazole, intermittent local 
and systemic metronidazole for bacterial 
vaginosis, and intermittent fluconazole 
for yeast vaginitis following 
metronidazole therapy. She was 
asymptomatic at the time of her 
evaluation including negative vaginal 
microscopy, pH, and whiff testing.  She 
was advised to follow vulvar skin care 
guidelines, including avoidance of 
scented laundry, bathing, and cosmetic 
items.  She also began a trial of 
probiotics with Kefir.   
Despite compliance with these 
measures, symptoms returned at 
approximately 2, 6, and 7 months 
following her initial appointment.  On 
evaluation, she was found to have 
bacterial vaginosis each time, confirmed 
by clinical exam, microscopy, pH, and 
whiff testing.  Oral metronidazole and 
oral fluconazole (prophylaxis) were 
prescribed for each encounter with 
reported symptom resolution.  Following 
the 3rd recurrent bacterial vaginosis 
episode, she received treatment with 
vaginal and vulvar 1% gentian violet 
painting, and was also advised to use 
vaginal 0.75% metronidazole vaginal gel 
prophylactically following intercourse 
and menses.  Despite prophylaxis, she 
was diagnosed with bacterial vaginosis 
again 2 weeks and 2 months later.  
Ten months following her initial referral 
to our center, she was diagnosed with 
Helicobacter pylori (H. pylori) following 
presentation with symptoms of nausea, 
abdominal pain, and weight loss.  
Symptoms had worsened acutely; 
however, she had a long history of 
gastro-esophageal reflux disease 
(GERD) poorly controlled with trials of 
histamine-receptor blockers and 
omeprazole.  When found to be H. pylori 
antibody positive, she was treated with 
triple therapy consisting of amoxicillin, 
clarithromycin, and omeprazole, with 
confirmed eradication of the bacteria 
following therapy.  Six months following 
triple therapy, she has remained 
clinically asymptomatic for bacterial 
vaginosis with no further prophylaxis or 
changes to her medical or sexual 
history.   
Discussion 
Recurrent bacterial vaginosis 
Bacterial vaginosis occurs when 
bacterial species such as Gardnerella 
vaginalis, Atopobium vaginae, and 
Mobiluncus species replace the normal 
vaginal flora.6 This alteration inhibits 
lactobacillus from maintaining a vaginal 
environment conducive to inhibiting 
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infection with other bacteria and viruses.  
The mechanism by which the floral 
imbalance occurs and the role of sexual 
activity in the pathogenesis of bacterial 
vaginosis are not clear, but formation of 
an epithelial biofilm containing 
Gardnerella vaginalis appears to play an 
important role.7,8 Bacterial vaginosis has 
often been associated with sexual 
activity, with multiple studies 
demonstrating associations between 
bacterial vaginosis and new sexual 
partners, multiple sexual partners, and 
lack of condom use.9  While a significant 
risk factor, 15% of women with bacterial 
vaginosis deny any history of sexual 
intercourse.1  Women who have sex 
with women are also at increased risk 
for bacterial vaginosis, with increased 
number of female partners showing a 
greater association.10 Other risk factors 
for bacterial vaginosis include taking 4 
or more baths in a week, having more 
than 2 live births, and douching.11 Use 
of oral contraceptive pills appears to be 
protective. 
The Center for Disease Control 
recommended treatment regimens 
include oral metronidazole 500 mg twice 
daily for 7 days, intravaginal 0.75% 
metronidazole gel for 5 days, or 
intravaginal 2% clindamycin cream for 7 
days.12 All 3 treatment modalities have 
been shown to have roughly equivalent 
effectiveness in curing bacterial 
vaginosis with similar rates of disease 
recurrence.13 The recurrence rates 
following all treatments are high. One 
study following women treated with oral 
metronidazole found recurrence rates of 
23% at 1 month post-treatment and 68% 
at 12 months post-treatment.14 Several 
reasons have been suggested for this 
high rate of recurrence: failure of normal 
vaginal flora to take hold post treatment, 
reinfection through sexual encounters, 
antibiotic resistance, and the 
persistence of a polymicrobial vaginal 
biofilm. For these reasons, condom use 
is recommended for 3-6 months 
following treatment.15 Evidence showing 
that treatment of sexual partners and 
recolonization with lactobacillus 
supplements is lacking. Prophylactic 
0.75% metronidazole vaginal gel has 
been shown to prevent recurrence 
compared to placebo, but over half of 
women still have recurrent bacterial 
vaginosis at 28 weeks.16 Also, a higher 
proportion of women treated with 
prophylactic metronidazole (43.1%) 
suffered from vulvovaginal candidiasis in 
this time period due to the effects of 
chronic antibiotic therapy.   
Link between bacterial vaginosis and 
Helicobacter pylori? 
Evidence linking H pylori infection with 
bacterial vaginosis is lacking; however, 
several theoretical links exist. H pylori 
has been shown to colonize yeast within 
the vagina and has also been 
associated with biofilm formation, 
making it possible that H pylori is one of 
many bacterial species seen in biofilms 
present in bacterial vaginosis leading to 
treatment failure. H pylori is commonly 
found in the stomach and upper 
gastrointestinal tract, one of the few 
bacteria able to colonize this acidic 
environment.17 Eslick hypothesized that 
H pylori may be able to also colonize the 
acidic vaginal environment, acting as a 
reservoir and allowing sexual 
transmission of the bacteria.   
H pylori isolates have also been found 
to have an endosymbiotic relationship 
with Candida albicans, with bacteria 
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isolated from within these yeast.18 This 
relationship may allow H pylori to 
colonize the vagina. Candida isolated 
from the vagina has been found to 
contain H pylori specific genes, one 
mechanism for the vertical transmission 
of H pylori.19 The colonization of the 
vagina by H pylori may contribute to the 
high rates of treatment failure and 
infection recurrence in some women 
with bacterial vaginosis. 
Many women with recurrent bacterial 
vaginosis have vaginal epithelium 
coated in polymicrobial biofilms, 
primarily composed of Gardnerella 
vaginosis.20 This biofilm is not 
completely eliminated by recommended 
treatments, including oral 
metronidazole.8 Antibiotic therapy 
induces a dormant state in the biofilm, 
which subsequently reverts to a live 
state again following treatment, leading 
to recurrent symptoms of bacterial 
vaginosis. Recurrent treatment against 
biofilms also leads to increased bacterial 
resistance against commonly used 
antimicrobial agents. A similar effect 
occurs with H pylori dominant biofilms in 
the gastric mucosa, leading to treatment 
resistance and disease recurrence.21 
Conclusion 
Improved therapeutic solutions are 
needed for women who suffer from 
bacterial vaginosis. Current therapies 
perform poorly in reducing infection. 
While the mechanisms behind 
recurrence of bacterial vaginosis are 
likely myriad, one potential reason may 
be coinfection with Helicobacter pylori. 
The patient in this case report suffered 
from recurrent bacterial vaginosis 
despite multiple treatments with oral 
metronidazole and prophylaxis with 
metronidazole gel. Six months following 
eradication of her H pylori infection, she 
has remained clinically asymptomatic for 
bacterial vaginosis.   
While association does not imply 
causation, similar mechanisms of 
pathogenesis and the prolonged 
remission experienced following 
treatment for H pylori may warrant 
investigation as a potential contributing 
etiology to recurrent bacterial vaginosis.   
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